1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Indometacin (Indomethacin) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Tablet 1.2.3 Capsule 1.2.4 Suppository 1.2.5 Injection 1.2.6 Patch 1.2.7 Gelatin Pearl 1.2.8 Cream 1.2.9 Other 1.3 Market by Application 1.3.1 Global Indometacin (Indomethacin) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Nonsteroidal Anti-Inflammatory Drugs 1.3.3 Topical Administration For Joint And Muscle Pain 1.3.4 Western Medicine Carcinogenic Pain Medicine 1.3.5 Dysmenorrheal 1.3.6 Batter Syndrome 1.3.7 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Indometacin (Indomethacin) Market Perspective (2016-2027) 2.2 Indometacin (Indomethacin) Growth Trends by Regions 2.2.1 Indometacin (Indomethacin) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Indometacin (Indomethacin) Historic Market Share by Regions (2016-2021) 2.2.3 Indometacin (Indomethacin) Forecasted Market Size by Regions (2022-2027) 2.3 Indometacin (Indomethacin) Industry Dynamic 2.3.1 Indometacin (Indomethacin) Market Trends 2.3.2 Indometacin (Indomethacin) Market Drivers 2.3.3 Indometacin (Indomethacin) Market Challenges 2.3.4 Indometacin (Indomethacin) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Indometacin (Indomethacin) Players by Revenue 3.1.1 Global Top Indometacin (Indomethacin) Players by Revenue (2016-2021) 3.1.2 Global Indometacin (Indomethacin) Revenue Market Share by Players (2016-2021) 3.2 Global Indometacin (Indomethacin) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Indometacin (Indomethacin) Revenue 3.4 Global Indometacin (Indomethacin) Market Concentration Ratio 3.4.1 Global Indometacin (Indomethacin) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Indometacin (Indomethacin) Revenue in 2020 3.5 Indometacin (Indomethacin) Key Players Head office and Area Served 3.6 Key Players Indometacin (Indomethacin) Product Solution and Service 3.7 Date of Enter into Indometacin (Indomethacin) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Indometacin (Indomethacin) Breakdown Data by Type 4.1 Global Indometacin (Indomethacin) Historic Market Size by Type (2016-2021) 4.2 Global Indometacin (Indomethacin) Forecasted Market Size by Type (2022-2027) 5 Indometacin (Indomethacin) Breakdown Data by Application 5.1 Global Indometacin (Indomethacin) Historic Market Size by Application (2016-2021) 5.2 Global Indometacin (Indomethacin) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Indometacin (Indomethacin) Market Size (2016-2027) 6.2 North America Indometacin (Indomethacin) Market Size by Type 6.2.1 North America Indometacin (Indomethacin) Market Size by Type (2016-2021) 6.2.2 North America Indometacin (Indomethacin) Market Size by Type (2022-2027) 6.2.3 North America Indometacin (Indomethacin) Market Size by Type (2016-2027) 6.3 North America Indometacin (Indomethacin) Market Size by Application 6.3.1 North America Indometacin (Indomethacin) Market Size by Application (2016-2021) 6.3.2 North America Indometacin (Indomethacin) Market Size by Application (2022-2027) 6.3.3 North America Indometacin (Indomethacin) Market Size by Application (2016-2027) 6.4 North America Indometacin (Indomethacin) Market Size by Country 6.4.1 North America Indometacin (Indomethacin) Market Size by Country (2016-2021) 6.4.2 North America Indometacin (Indomethacin) Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Indometacin (Indomethacin) Market Size (2016-2027) 7.2 Europe Indometacin (Indomethacin) Market Size by Type 7.2.1 Europe Indometacin (Indomethacin) Market Size by Type (2016-2021) 7.2.2 Europe Indometacin (Indomethacin) Market Size by Type (2022-2027) 7.2.3 Europe Indometacin (Indomethacin) Market Size by Type (2016-2027) 7.3 Europe Indometacin (Indomethacin) Market Size by Application 7.3.1 Europe Indometacin (Indomethacin) Market Size by Application (2016-2021) 7.3.2 Europe Indometacin (Indomethacin) Market Size by Application (2022-2027) 7.3.3 Europe Indometacin (Indomethacin) Market Size by Application (2016-2027) 7.4 Europe Indometacin (Indomethacin) Market Size by Country 7.4.1 Europe Indometacin (Indomethacin) Market Size by Country (2016-2021) 7.4.2 Europe Indometacin (Indomethacin) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Indometacin (Indomethacin) Market Size (2016-2027) 8.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Type 8.2.1 Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2016-2027) 8.3 Asia-Pacific Indometacin (Indomethacin) Market Size by Application 8.3.1 Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2016-2027) 8.4 Asia-Pacific Indometacin (Indomethacin) Market Size by Region 8.4.1 Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Indometacin (Indomethacin) Market Size (2016-2027) 9.2 Latin America Indometacin (Indomethacin) Market Size by Type 9.2.1 Latin America Indometacin (Indomethacin) Market Size by Type (2016-2021) 9.2.2 Latin America Indometacin (Indomethacin) Market Size by Type (2022-2027) 9.2.3 Latin America Indometacin (Indomethacin) Market Size by Type (2016-2027) 9.3 Latin America Indometacin (Indomethacin) Market Size by Application 9.3.1 Latin America Indometacin (Indomethacin) Market Size by Application (2016-2021) 9.3.2 Latin America Indometacin (Indomethacin) Market Size by Application (2022-2027) 9.3.3 Latin America Indometacin (Indomethacin) Market Size by Application (2016-2027) 9.4 Latin America Indometacin (Indomethacin) Market Size by Country 9.4.1 Latin America Indometacin (Indomethacin) Market Size by Country (2016-2021) 9.4.2 Latin America Indometacin (Indomethacin) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Indometacin (Indomethacin) Market Size (2016-2027) 10.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Type 10.2.1 Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2016-2027) 10.3 Middle East & Africa Indometacin (Indomethacin) Market Size by Application 10.3.1 Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2016-2027) 10.4 Middle East & Africa Indometacin (Indomethacin) Market Size by Country 10.4.1 Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Iroko Pharma 11.1.1 Iroko Pharma Company Details 11.1.2 Iroko Pharma Business Overview 11.1.3 Iroko Pharma Indometacin (Indomethacin) Introduction 11.1.4 Iroko Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.1.5 Iroko Pharma Recent Development 11.2 Zyla Life Sciences 11.2.1 Zyla Life Sciences Company Details 11.2.2 Zyla Life Sciences Business Overview 11.2.3 Zyla Life Sciences Indometacin (Indomethacin) Introduction 11.2.4 Zyla Life Sciences Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.2.5 Zyla Life Sciences Recent Development 11.3 Kowa 11.3.1 Kowa Company Details 11.3.2 Kowa Business Overview 11.3.3 Kowa Indometacin (Indomethacin) Introduction 11.3.4 Kowa Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.3.5 Kowa Recent Development 11.4 Merck 11.4.1 Merck Company Details 11.4.2 Merck Business Overview 11.4.3 Merck Indometacin (Indomethacin) Introduction 11.4.4 Merck Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.4.5 Merck Recent Development 11.5 H. Lumdbeck 11.5.1 H. Lumdbeck Company Details 11.5.2 H. Lumdbeck Business Overview 11.5.3 H. Lumdbeck Indometacin (Indomethacin) Introduction 11.5.4 H. Lumdbeck Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.5.5 H. Lumdbeck Recent Development 11.6 Recordati 11.6.1 Recordati Company Details 11.6.2 Recordati Business Overview 11.6.3 Recordati Indometacin (Indomethacin) Introduction 11.6.4 Recordati Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.6.5 Recordati Recent Development 11.7 Druggability Technologies 11.7.1 Druggability Technologies Company Details 11.7.2 Druggability Technologies Business Overview 11.7.3 Druggability Technologies Indometacin (Indomethacin) Introduction 11.7.4 Druggability Technologies Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.7.5 Druggability Technologies Recent Development 11.8 AlphaRx 11.8.1 AlphaRx Company Details 11.8.2 AlphaRx Business Overview 11.8.3 AlphaRx Indometacin (Indomethacin) Introduction 11.8.4 AlphaRx Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.8.5 AlphaRx Recent Development 11.9 Cypress Bioscience 11.9.1 Cypress Bioscience Company Details 11.9.2 Cypress Bioscience Business Overview 11.9.3 Cypress Bioscience Indometacin (Indomethacin) Introduction 11.9.4 Cypress Bioscience Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.9.5 Cypress Bioscience Recent Development 11.10 NAL Pharma 11.10.1 NAL Pharma Company Details 11.10.2 NAL Pharma Business Overview 11.10.3 NAL Pharma Indometacin (Indomethacin) Introduction 11.10.4 NAL Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.10.5 NAL Pharma Recent Development 11.11 Dr. Reddy’s 11.11.1 Dr. Reddy’s Company Details 11.11.2 Dr. Reddy’s Business Overview 11.11.3 Dr. Reddy’s Indometacin (Indomethacin) Introduction 11.11.4 Dr. Reddy’s Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.11.5 Dr. Reddy’s Recent Development 11.12 Provalis 11.12.1 Provalis Company Details 11.12.2 Provalis Business Overview 11.12.3 Provalis Indometacin (Indomethacin) Introduction 11.12.4 Provalis Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.12.5 Provalis Recent Development 11.13 NIPRO 11.13.1 NIPRO Company Details 11.13.2 NIPRO Business Overview 11.13.3 NIPRO Indometacin (Indomethacin) Introduction 11.13.4 NIPRO Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.13.5 NIPRO Recent Development 11.14 Shanghai Modern Pharmaceutical 11.14.1 Shanghai Modern Pharmaceutical Company Details 11.14.2 Shanghai Modern Pharmaceutical Business Overview 11.14.3 Shanghai Modern Pharmaceutical Indometacin (Indomethacin) Introduction 11.14.4 Shanghai Modern Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.14.5 Shanghai Modern Pharmaceutical Recent Development 11.15 Beijing Shuangji Pharmaceutical 11.15.1 Beijing Shuangji Pharmaceutical Company Details 11.15.2 Beijing Shuangji Pharmaceutical Business Overview 11.15.3 Beijing Shuangji Pharmaceutical Indometacin (Indomethacin) Introduction 11.15.4 Beijing Shuangji Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.15.5 Beijing Shuangji Pharmaceutical Recent Development 11.16 Sinopharm Group Industry 11.16.1 Sinopharm Group Industry Company Details 11.16.2 Sinopharm Group Industry Business Overview 11.16.3 Sinopharm Group Industry Indometacin (Indomethacin) Introduction 11.16.4 Sinopharm Group Industry Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.16.5 Sinopharm Group Industry Recent Development 11.17 Jiangsu Yuanheng Pharmaceutical 11.17.1 Jiangsu Yuanheng Pharmaceutical Company Details 11.17.2 Jiangsu Yuanheng Pharmaceutical Business Overview 11.17.3 Jiangsu Yuanheng Pharmaceutical Indometacin (Indomethacin) Introduction 11.17.4 Jiangsu Yuanheng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.17.5 Jiangsu Yuanheng Pharmaceutical Recent Development 11.18 Hubei Dongxin Pharmaceutical 11.18.1 Hubei Dongxin Pharmaceutical Company Details 11.18.2 Hubei Dongxin Pharmaceutical Business Overview 11.18.3 Hubei Dongxin Pharmaceutical Indometacin (Indomethacin) Introduction 11.18.4 Hubei Dongxin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.18.5 Hubei Dongxin Pharmaceutical Recent Development 11.18 Ma Yinglong Pharmaceutical Group 11.25.1 Ma Yinglong Pharmaceutical Group Company Details 11.25.2 Ma Yinglong Pharmaceutical Group Business Overview 11.25.3 Ma Yinglong Pharmaceutical Group Indometacin (Indomethacin) Introduction 11.25.4 Ma Yinglong Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.25.5 Ma Yinglong Pharmaceutical Group Recent Development 11.20 Shanghai New Yellow River Pharmaceutical Co. , Ltd. 11.20.1 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Company Details 11.20.2 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Business Overview 11.20.3 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Indometacin (Indomethacin) Introduction 11.20.4 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.20.5 Shanghai New Yellow River Pharmaceutical Co. , Ltd. Recent Development 11.21 JBH Pharmaceutical Group 11.21.1 JBH Pharmaceutical Group Company Details 11.21.2 JBH Pharmaceutical Group Business Overview 11.21.3 JBH Pharmaceutical Group Indometacin (Indomethacin) Introduction 11.21.4 JBH Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.21.5 JBH Pharmaceutical Group Recent Development 11.22 Linfen Baozhu Pharmaceutical 11.22.1 Linfen Baozhu Pharmaceutical Company Details 11.22.2 Linfen Baozhu Pharmaceutical Business Overview 11.22.3 Linfen Baozhu Pharmaceutical Indometacin (Indomethacin) Introduction 11.22.4 Linfen Baozhu Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.22.5 Linfen Baozhu Pharmaceutical Recent Development 11.23 Shanxi Yunpeng Pharmaceutical 11.23.1 Shanxi Yunpeng Pharmaceutical Company Details 11.23.2 Shanxi Yunpeng Pharmaceutical Business Overview 11.23.3 Shanxi Yunpeng Pharmaceutical Indometacin (Indomethacin) Introduction 11.23.4 Shanxi Yunpeng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.23.5 Shanxi Yunpeng Pharmaceutical Recent Development 11.24 Shanxi Taiyuan Pharmaceutical 11.24.1 Shanxi Taiyuan Pharmaceutical Company Details 11.24.2 Shanxi Taiyuan Pharmaceutical Business Overview 11.24.3 Shanxi Taiyuan Pharmaceutical Indometacin (Indomethacin) Introduction 11.24.4 Shanxi Taiyuan Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.24.5 Shanxi Taiyuan Pharmaceutical Recent Development 11.25 Guangdong Sancai Shiqi District Pharmaceutical 11.25.1 Guangdong Sancai Shiqi District Pharmaceutical Company Details 11.25.2 Guangdong Sancai Shiqi District Pharmaceutical Business Overview 11.25.3 Guangdong Sancai Shiqi District Pharmaceutical Indometacin (Indomethacin) Introduction 11.25.4 Guangdong Sancai Shiqi District Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.25.5 Guangdong Sancai Shiqi District Pharmaceutical Recent Development 11.26 Guangdong South China Pharmaceutical Group 11.26.1 Guangdong South China Pharmaceutical Group Company Details 11.26.2 Guangdong South China Pharmaceutical Group Business Overview 11.26.3 Guangdong South China Pharmaceutical Group Indometacin (Indomethacin) Introduction 11.26.4 Guangdong South China Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.26.5 Guangdong South China Pharmaceutical Group Recent Development 11.27 Jiangsu Yabang Aipusen Pharmaceutical 11.27.1 Jiangsu Yabang Aipusen Pharmaceutical Company Details 11.27.2 Jiangsu Yabang Aipusen Pharmaceutical Business Overview 11.27.3 Jiangsu Yabang Aipusen Pharmaceutical Indometacin (Indomethacin) Introduction 11.27.4 Jiangsu Yabang Aipusen Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.27.5 Jiangsu Yabang Aipusen Pharmaceutical Recent Development 11.28 Chongqing Kerui Pharmaceutical Group 11.28.1 Chongqing Kerui Pharmaceutical Group Company Details 11.28.2 Chongqing Kerui Pharmaceutical Group Business Overview 11.28.3 Chongqing Kerui Pharmaceutical Group Indometacin (Indomethacin) Introduction 11.28.4 Chongqing Kerui Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.28.5 Chongqing Kerui Pharmaceutical Group Recent Development 11.29 Beijing Honglin Pharmaceutical 11.29.1 Beijing Honglin Pharmaceutical Company Details 11.29.2 Beijing Honglin Pharmaceutical Business Overview 11.29.3 Beijing Honglin Pharmaceutical Indometacin (Indomethacin) Introduction 11.29.4 Beijing Honglin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.29.5 Beijing Honglin Pharmaceutical Recent Development 11.30 Suzhou No. 3 Pharmaceutical Factory 11.30.1 Suzhou No. 3 Pharmaceutical Factory Company Details 11.30.2 Suzhou No. 3 Pharmaceutical Factory Business Overview 11.30.3 Suzhou No. 3 Pharmaceutical Factory Indometacin (Indomethacin) Introduction 11.30.4 Suzhou No. 3 Pharmaceutical Factory Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.30.5 Suzhou No. 3 Pharmaceutical Factory Recent Development 11.31 Bedford Pharma 11.31.1 Bedford Pharma Company Details 11.31.2 Bedford Pharma Business Overview 11.31.3 Bedford Pharma Indometacin (Indomethacin) Introduction 11.31.4 Bedford Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.31.5 Bedford Pharma Recent Development 11.32 Northwind Pharmaceuticals 11.32.1 Northwind Pharmaceuticals Company Details 11.32.2 Northwind Pharmaceuticals Business Overview 11.32.3 Northwind Pharmaceuticals Indometacin (Indomethacin) Introduction 11.32.4 Northwind Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.32.5 Northwind Pharmaceuticals Recent Development 11.33 PD-Rx Pharmaceuticals 11.33.1 PD-Rx Pharmaceuticals Company Details 11.33.2 PD-Rx Pharmaceuticals Business Overview 11.33.3 PD-Rx Pharmaceuticals Indometacin (Indomethacin) Introduction 11.33.4 PD-Rx Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021) 11.33.5 PD-Rx Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Indometacin (Indomethacin) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Tablet Table 3. Key Players of Capsule Table 4. Key Players of Suppository Table 5. Key Players of Injection Table 6. Key Players of Patch Table 7. Key Players of Gelatin Pearl Table 8. Key Players of Cream Table 9. Key Players of Other Table 10. Global Indometacin (Indomethacin) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Indometacin (Indomethacin) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Indometacin (Indomethacin) Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Indometacin (Indomethacin) Market Share by Regions (2016-2021) Table 14. Global Indometacin (Indomethacin) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Indometacin (Indomethacin) Market Share by Regions (2022-2027) Table 16. Indometacin (Indomethacin) Market Trends Table 17. Indometacin (Indomethacin) Market Drivers Table 18. Indometacin (Indomethacin) Market Challenges Table 19. Indometacin (Indomethacin) Market Restraints Table 20. Global Indometacin (Indomethacin) Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Indometacin (Indomethacin) Market Share by Players (2016-2021) Table 22. Global Top Indometacin (Indomethacin) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Indometacin (Indomethacin) as of 2020) Table 23. Ranking of Global Top Indometacin (Indomethacin) Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Indometacin (Indomethacin) Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Indometacin (Indomethacin) Product Solution and Service Table 27. Date of Enter into Indometacin (Indomethacin) Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million) Table 30. Global Indometacin (Indomethacin) Revenue Market Share by Type (2016-2021) Table 31. Global Indometacin (Indomethacin) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Indometacin (Indomethacin) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Indometacin (Indomethacin) Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Indometacin (Indomethacin) Revenue Market Share by Application (2016-2021) Table 35. Global Indometacin (Indomethacin) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Indometacin (Indomethacin) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million) Table 38. North America Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million) Table 40. North America Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Indometacin (Indomethacin) Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Indometacin (Indomethacin) Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Indometacin (Indomethacin) Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Indometacin (Indomethacin) Market Size by Country (2022-2027) & (US$ Million) Table 67. Iroko Pharma Company Details Table 68. Iroko Pharma Business Overview Table 69. Iroko Pharma Indometacin (Indomethacin) Product Table 70. Iroko Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 71. Iroko Pharma Recent Development Table 72. Zyla Life Sciences Company Details Table 73. Zyla Life Sciences Business Overview Table 74. Zyla Life Sciences Indometacin (Indomethacin) Product Table 75. Zyla Life Sciences Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 76. Zyla Life Sciences Recent Development Table 77. Kowa Company Details Table 78. Kowa Business Overview Table 79. Kowa Indometacin (Indomethacin) Product Table 80. Kowa Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 81. Kowa Recent Development Table 82. Merck Company Details Table 83. Merck Business Overview Table 84. Merck Indometacin (Indomethacin) Product Table 85. Merck Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 86. Merck Recent Development Table 87. H. Lumdbeck Company Details Table 88. H. Lumdbeck Business Overview Table 89. H. Lumdbeck Indometacin (Indomethacin) Product Table 90. H. Lumdbeck Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 91. H. Lumdbeck Recent Development Table 92. Recordati Company Details Table 93. Recordati Business Overview Table 94. Recordati Indometacin (Indomethacin) Product Table 95. Recordati Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 96. Recordati Recent Development Table 97. Druggability Technologies Company Details Table 98. Druggability Technologies Business Overview Table 99. Druggability Technologies Indometacin (Indomethacin) Product Table 100. Druggability Technologies Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 101. Druggability Technologies Recent Development Table 102. AlphaRx Company Details Table 103. AlphaRx Business Overview Table 104. AlphaRx Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 105. AlphaRx Recent Development Table 106. Cypress Bioscience Company Details Table 107. Cypress Bioscience Business Overview Table 108. Cypress Bioscience Indometacin (Indomethacin) Product Table 109. Cypress Bioscience Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 110. Cypress Bioscience Recent Development Table 111. NAL Pharma Company Details Table 112. NAL Pharma Business Overview Table 113. NAL Pharma Indometacin (Indomethacin) Product Table 114. NAL Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 115. NAL Pharma Recent Development Table 116. Dr. Reddy’s Company Details Table 117. Dr. Reddy’s Business Overview Table 118. Dr. Reddy’s Indometacin (Indomethacin) Product Table 119. Dr. Reddy’s Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 120. Dr. Reddy’s Recent Development Table 121. Provalis Company Details Table 122. Provalis Business Overview Table 123. Provalis Indometacin (Indomethacin) Product Table 124. Provalis Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 125. Provalis Recent Development Table 126. NIPRO Company Details Table 127. NIPRO Business Overview Table 128. NIPRO Indometacin (Indomethacin) Product Table 129. NIPRO Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 130. NIPRO Recent Development Table 131. Shanghai Modern Pharmaceutical Company Details Table 132. Shanghai Modern Pharmaceutical Business Overview Table 133. Shanghai Modern Pharmaceutical Indometacin (Indomethacin) Product Table 134. Shanghai Modern Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 135. Shanghai Modern Pharmaceutical Recent Development Table 136. Beijing Shuangji Pharmaceutical Company Details Table 137. Beijing Shuangji Pharmaceutical Business Overview Table 138. Beijing Shuangji Pharmaceutical Indometacin (Indomethacin) Product Table 139. Beijing Shuangji Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 140. Beijing Shuangji Pharmaceutical Recent Development Table 141. Sinopharm Group Industry Company Details Table 142. Sinopharm Group Industry Business Overview Table 143. Sinopharm Group Industry Indometacin (Indomethacin) Product Table 144. Sinopharm Group Industry Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 145. Sinopharm Group Industry Recent Development Table 146. Jiangsu Yuanheng Pharmaceutical Company Details Table 147. Jiangsu Yuanheng Pharmaceutical Business Overview Table 148. Jiangsu Yuanheng Pharmaceutical Indometacin (Indomethacin) Product Table 149. Jiangsu Yuanheng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 150. Jiangsu Yuanheng Pharmaceutical Recent Development Table 151. Hubei Dongxin Pharmaceutical Company Details Table 152. Hubei Dongxin Pharmaceutical Business Overview Table 153. Hubei Dongxin Pharmaceutical Indometacin (Indomethacin) Product Table 154. Hubei Dongxin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 155. Hubei Dongxin Pharmaceutical Recent Development Table 156. Ma Yinglong Pharmaceutical Group Company Details Table 157. Ma Yinglong Pharmaceutical Group Business Overview Table 158. Ma Yinglong Pharmaceutical Group Indometacin (Indomethacin) Product Table 159. Ma Yinglong Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 160. Ma Yinglong Pharmaceutical Group Recent Development Table 161. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Company Details Table 162. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Business Overview Table 163. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Indometacin (Indomethacin) Product Table 164. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 165. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Recent Development Table 166. JBH Pharmaceutical Group Company Details Table 167. JBH Pharmaceutical Group Business Overview Table 168. JBH Pharmaceutical Group Indometacin (Indomethacin) Product Table 169. JBH Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 170. JBH Pharmaceutical Group Recent Development Table 171. Linfen Baozhu Pharmaceutical Company Details Table 172. Linfen Baozhu Pharmaceutical Business Overview Table 173. Linfen Baozhu Pharmaceutical Indometacin (Indomethacin) Product Table 174. Linfen Baozhu Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 175. Linfen Baozhu Pharmaceutical Recent Development Table 176. Shanxi Yunpeng Pharmaceutical Company Details Table 177. Shanxi Yunpeng Pharmaceutical Business Overview Table 178. Shanxi Yunpeng Pharmaceutical Indometacin (Indomethacin) Product Table 179. Shanxi Yunpeng Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 180. Shanxi Yunpeng Pharmaceutical Recent Development Table 181. Shanxi Taiyuan Pharmaceutical Company Details Table 182. Shanxi Taiyuan Pharmaceutical Business Overview Table 183. Shanxi Taiyuan Pharmaceutical Indometacin (Indomethacin)Product Table 184. Shanxi Taiyuan Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 185. Shanxi Taiyuan Pharmaceutical Recent Development Table 186. Guangdong Sancai Shiqi District Pharmaceutical Company Details Table 187. Guangdong Sancai Shiqi District Pharmaceutical Business Overview Table 188. Guangdong Sancai Shiqi District Pharmaceutical Indometacin (Indomethacin) Product Table 189. Guangdong Sancai Shiqi District Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 190. Guangdong Sancai Shiqi District Pharmaceutical Recent Development Table 191. Guangdong South China Pharmaceutical Group Company Details Table 192. Guangdong South China Pharmaceutical Group Business Overview Table 193. Guangdong South China Pharmaceutical Group Indometacin (Indomethacin) Product Table 194. Guangdong South China Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 195. Guangdong South China Pharmaceutical Group Recent Development Table 196. Jiangsu Yabang Aipusen Pharmaceutical Company Details Table 197. Jiangsu Yabang Aipusen Pharmaceutical Business Overview Table 198. Jiangsu Yabang Aipusen Pharmaceutical Indometacin (Indomethacin) Product Table 199. Jiangsu Yabang Aipusen Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 200. Jiangsu Yabang Aipusen Pharmaceutical Recent Development Table 201. Chongqing Kerui Pharmaceutical Group Company Details Table 202. Chongqing Kerui Pharmaceutical Group Business Overview Table 203. Chongqing Kerui Pharmaceutical Group Indometacin (Indomethacin) Product Table 204. Chongqing Kerui Pharmaceutical Group Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 205. Chongqing Kerui Pharmaceutical Group Recent Development Table 206. Beijing Honglin Pharmaceutical Company Details Table 207. Beijing Honglin Pharmaceutical Business Overview Table 208. Beijing Honglin Pharmaceutical Indometacin (Indomethacin) Product Table 209. Beijing Honglin Pharmaceutical Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 210. Beijing Honglin Pharmaceutical Recent Development Table 211. Suzhou No. 3 Pharmaceutical Factory Company Details Table 212. Suzhou No. 3 Pharmaceutical Factory Business Overview Table 213. Suzhou No. 3 Pharmaceutical Factory Indometacin (Indomethacin) Product Table 214. Suzhou No. 3 Pharmaceutical Factory Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 215. Suzhou No. 3 Pharmaceutical Factory Recent Development Table 216. Bedford Pharma Company Details Table 217. Bedford Pharma Business Overview Table 218. Bedford Pharma Indometacin (Indomethacin) Product Table 219. Bedford Pharma Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 220. Bedford Pharma Recent Development Table 221. Northwind Pharmaceuticals Company Details Table 222. Northwind Pharmaceuticals Business Overview Table 223. Northwind Pharmaceuticals Indometacin (Indomethacin) Product Table 224. Northwind Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 225. Northwind Pharmaceuticals Recent Development Table 226. PD-Rx Pharmaceuticals Company Details Table 227. PD-Rx Pharmaceuticals Business Overview Table 228. PD-Rx Pharmaceuticals Indometacin (Indomethacin) Product Table 229. PD-Rx Pharmaceuticals Revenue in Indometacin (Indomethacin) Business (2016-2021) & (US$ Million) Table 230. PD-Rx Pharmaceuticals Recent Development Table 231. Research Programs/Design for This Report Table 232. Key Data Information from Secondary Sources Table 233. Key Data Information from Primary Sources List of Figures Figure 1. Global Indometacin (Indomethacin) Market Share by Type: 2020 VS 2027 Figure 2. Tablet Features Figure 3. Capsule Features Figure 4. Suppository Features Figure 5. Injection Features Figure 6. Patch Features Figure 7. Gelatin Pearl Features Figure 8. Cream Features Figure 9. Other Features Figure 10. Global Indometacin (Indomethacin) Market Share by Application: 2020 VS 2027 Figure 11. Nonsteroidal Anti-Inflammatory Drugs Case Studies Figure 12. Topical Administration For Joint And Muscle Pain Case Studies Figure 13. Western Medicine Carcinogenic Pain Medicine Case Studies Figure 14. Dysmenorrheal Case Studies Figure 15. Batter Syndrome Case Studies Figure 16. Other Case Studies Figure 17. Indometacin (Indomethacin) Report Years Considered Figure 18. Global Indometacin (Indomethacin) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 19. Global Indometacin (Indomethacin) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 20. Global Indometacin (Indomethacin) Market Share by Regions: 2020 VS 2027 Figure 21. Global Indometacin (Indomethacin) Market Share by Regions (2022-2027) Figure 22. Global Indometacin (Indomethacin) Market Share by Players in 2020 Figure 23. Global Top Indometacin (Indomethacin) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Indometacin (Indomethacin) as of 2020 Figure 24. The Top 10 and 5 Players Market Share by Indometacin (Indomethacin) Revenue in 2020 Figure 25. Global Indometacin (Indomethacin) Revenue Market Share by Type (2016-2021) Figure 26. Global Indometacin (Indomethacin) Revenue Market Share by Type (2022-2027) Figure 27. North America Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. North America Indometacin (Indomethacin) Market Share by Type (2016-2027) Figure 29. North America Indometacin (Indomethacin) Market Share by Application (2016-2027) Figure 30. North America Indometacin (Indomethacin) Market Share by Country (2016-2027) Figure 31. United States Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Canada Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Europe Indometacin (Indomethacin) Market Share by Type (2016-2027) Figure 35. Europe Indometacin (Indomethacin) Market Share by Application (2016-2027) Figure 36. Europe Indometacin (Indomethacin) Market Share by Country (2016-2027) Figure 37. Germany Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. France Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. U.K. Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Italy Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Russia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Nordic Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Asia-Pacific Indometacin (Indomethacin) Market Share by Type (2016-2027) Figure 45. Asia-Pacific Indometacin (Indomethacin) Market Share by Application (2016-2027) Figure 46. Asia-Pacific Indometacin (Indomethacin) Market Share by Region (2016-2027) Figure 47. China Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Japan Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. South Korea Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Southeast Asia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. India Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Australia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Latin America Indometacin (Indomethacin) Market Share by Type (2016-2027) Figure 55. Latin America Indometacin (Indomethacin) Market Share by Application (2016-2027) Figure 56. Latin America Indometacin (Indomethacin) Market Share by Country (2016-2027) Figure 57. Mexico Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Brazil Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Middle East & Africa Indometacin (Indomethacin) Market Share by Type (2016-2027) Figure 61. Middle East & Africa Indometacin (Indomethacin) Market Share by Application (2016-2027) Figure 62. Middle East & Africa Indometacin (Indomethacin) Market Share by Country (2016-2027) Figure 63. Turkey Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Saudi Arabia Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. UAE Indometacin (Indomethacin) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 66. Iroko Pharma Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 67. Zyla Life Sciences Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 68. Kowa Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 69. Merck Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 70. H. Lumdbeck Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 71. Recordati Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 72. Druggability Technologies Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 73. AlphaRx Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 74. Cypress Bioscience Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 75. NAL Pharma Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 76. Dr. Reddy’s Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 77. Provalis Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 78. NIPRO Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 79. Shanghai Modern Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 80. Beijing Shuangji Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 81. Sinopharm Group Industry Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 82. Jiangsu Yuanheng Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 83. Hubei Dongxin Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 84. Ma Yinglong Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 85. Shanghai New Yellow River Pharmaceutical Co. , Ltd. Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 86. JBH Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 87. Linfen Baozhu Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 88. Shanxi Yunpeng Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 89. Shanxi Taiyuan Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 90. Guangdong Sancai Shiqi District Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 91. Guangdong South China Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 92. Jiangsu Yabang Aipusen Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 93. Chongqing Kerui Pharmaceutical Group Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 94. Beijing Honglin Pharmaceutical Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 95. Suzhou No. 3 Pharmaceutical Factory Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 96. Bedford Pharma Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 97. Northwind Pharmaceuticals Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 98. PD-Rx Pharmaceuticals Revenue Growth Rate in Indometacin (Indomethacin) Business (2016-2021) Figure 99. Bottom-up and Top-down Approaches for This Report Figure 100. Data Triangulation Figure 101. Key Executives Interviewed

Iroko Pharma Zyla Life Sciences Kowa Merck H. Lumdbeck Recordati Druggability Technologies AlphaRx Cypress Bioscience NAL Pharma Dr. Reddy’s Provalis NIPRO Shanghai Modern Pharmaceutical Beijing Shuangji Pharmaceutical Sinopharm Group Industry Jiangsu Yuanheng Pharmaceutical Hubei Dongxin Pharmaceutical Ma Yinglong Pharmaceutical Group Shanghai New Yellow River Pharmaceutical Co. , Ltd. JBH Pharmaceutical Group Linfen Baozhu Pharmaceutical Shanxi Yunpeng Pharmaceutical Shanxi Taiyuan Pharmaceutical Guangdong Sancai Shiqi District Pharmaceutical Guangdong South China Pharmaceutical Group Jiangsu Yabang Aipusen Pharmaceutical Chongqing Kerui Pharmaceutical Group Beijing Honglin Pharmaceutical Suzhou No. 3 Pharmaceutical Factory Bedford Pharma Northwind Pharmaceuticals PD-Rx Pharmaceuticals